Skip to main content
Log in

High expression of long non-coding RNA Linc-A associates with poor survival in patients with colorectal cancer

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Long intergenic non-coding RNA for kinase activation (Linc-A) has been reported to enhance the occurrence and progression of breast cancer. Nevertheless, whether Linc-A is related to the tumorigenesis of colorectal cancer (CRC) remains unknown. In this study, we aimed to evaluate the expression of Linc-A in colon adenocarcinoma and explore the correlation between Linc-A and prognosis of CRC. The expression of Linc-A in human colon tissues was evaluated by qRT-PCR, which contained 15 pairs of human colon adenocarcinoma and paracancerous tissues and other 65 colon adenocarcinoma tissues. A total of 80 patients were divided into low and high expression groups according to the Linc-A levels. The levels of Linc-A in colon adenocarcinoma was higher than that in paracancerous tissues (p = 0.047). Furthermore, high expression of Linc-A was associated with advanced TNM stage (p = 0.013), positive lymph nodes (p = 0.024), low 5-year survival rate (p = 0.024) and even 10-year survival rate (p = 0.007). Besides, Linc-A, advanced age, advanced TNM stage, deep infiltration degree and positive lymph nodes were also found to be positively related to poor overall 5-year survival by Kaplan–Meier survival analysis(p < 0.05). Then, multivariable Cox regression analysis revealed that Linc-A was an independent risk factor for prognosis of colon adenocarcinoma (p = 0.047). In conclusion, high expression of Linc-A is associated with advanced TNM stage, lymphatic metastasis and poor survival in patients with CRC. Linc-A may be served as a candidate prognostic biomarker for CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–691

    Article  Google Scholar 

  2. Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, Fenwick SW, Halloran SP, Hochhauser D, Hull MA, Koelzer VH, McNair AGK, Monahan KJ, Nathke I, Norton C, Novelli MR, Steele RJC, Thomas AL, Wilde LM, Wilson RH, Tomlinson I, Bowel Cancer UK Critical Research Gaps in Colorectal Cancer Initiative (2018) Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 67:179–193

    Article  Google Scholar 

  3. Walsh JM, Terdiman JP (2003) Colorectal cancer screening: scientific review. JAMA 289:1288–1296

    Article  Google Scholar 

  4. Van Schaeybroeck S, Allen WL, Turkington RC, Johnston PG (2011) Implementing prognostic and predictive biomarkers in CRC clinical trials. Nat Rev Clin Oncol 8:222–232

    Article  Google Scholar 

  5. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159

    Article  CAS  Google Scholar 

  6. Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965–3981

    Article  CAS  Google Scholar 

  7. Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C, Li J, Ye Y, Yao J, Liang K, Wang S, Park PK, Marks JR, Zhou Y, Zhou J, Hung M-C, Liang H, Hu Z, Shen H, Hawke DH, Han L, Zhou Y, Lin C, Yang L (2017) The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol 19:238

    Article  CAS  Google Scholar 

  8. Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang G, Gao S, You Z, Zhan C, Liu F, Pang D (2015) Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol 8:4881–4891

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, Wei Y, Ma G, Park PK, Zhou J, Zhou Y, Hu Z, Zhou Y, Marks JR, Liang H, Hung MC, Lin C, Yang L (2016) The LINK-A lncRNA activates normoxic HIF1alpha signalling in triple-negative breast cancer. Nat Cell Biol 18:213–224

    Article  CAS  Google Scholar 

  10. Hua X, Li G, Liu Z, Niu Z (2019) LINK-A lncRNA participates in the pathogenesis of glioma by interacting with survivin. Exp Ther Med 18:1581–1586

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu J, Song W, Li J, Li X, Zhao R, Gong T (2019) LINK-A lncRNA is upregulated in metastatic non-small cell lung cancer and is associated with poor prognosis. Oncol Lett 18:3049–3057

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Huang ZY, Zhang LH, Zhao C, Liu R, Tong H, Gan C, Lan T, Tang CW, Gao JH (2018) High HIF-1 alpha expression predicts poor prognosis of patients with colon adenocarcinoma. Int J Clin Exp Patho 11:5635–5646

    CAS  Google Scholar 

  13. Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr (2019) Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 16:361–375

    Article  Google Scholar 

  14. Robertson DJ, Ladabaum U (2019) Opportunities and challenges in moving from current guidelines to personalized colorectal cancer screening. Gastroenterology 156:904–917

    Article  Google Scholar 

  15. Dekker E, Rex DK (2018) Advances in CRC prevention: screening and surveillance. Gastroenterology 154:1970–1984

    Article  Google Scholar 

  16. Vacante M, Borzì AM, Basile F, Biondi A (2018) Biomarkers in colorectal cancer: current clinical utility and future perspectives. World J Clin Cases 6:869–881

    Article  Google Scholar 

  17. Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B (2019) Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci 20(22):5758

    Article  CAS  Google Scholar 

  18. Stottrup C, Tsang T, Chin YR (2016) Upregulation of AKT3 confers resistance to the AKT inhibitor MK2206 in breast cancer. Mol Cancer Ther 15:1964–1974

    Article  CAS  Google Scholar 

  19. Li ZB, Chu HT, Jia M, Li L (2020) Long noncoding RNA LINC01139 promotes the progression of hepatocellular carcinoma by upregulating MYBL2 via competitively binding to miR-30 family. Biochem Biophys Res Commun 525:581–588

    Article  CAS  Google Scholar 

  20. Zhao W, Li W, Dai W, Huang N, Qiu J (2018) LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer. Onco Targets Ther 11:6071–6080

    Article  CAS  Google Scholar 

  21. Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J (2011) Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol 55:838–845

    Article  CAS  Google Scholar 

  22. Park MY, Kim KR, Park HS, Park BH, Choi HN, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS (2007) Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Int J Oncol 31:1309–1315

    CAS  PubMed  Google Scholar 

  23. Zhang W, Yuan W, Song J, Wang S, Gu X (2017) LncRna CPS1-IT1 suppresses cell proliferation, invasion and metastasis in colorectal cancer. Cell Physiol Biochem 44:567–580

    Article  Google Scholar 

  24. Padua Alves C, Fonseca AS, Muys BR, de Barros ELBR, Burger MC, de Souza JE, Valente V, Zago MA, Silva WA Jr (2013) Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 31:2827–2832

    Article  Google Scholar 

  25. Xu W, Yang Z, Lu N (2015) A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr 9:317–324

    Article  CAS  Google Scholar 

  26. Alzahrani AS (2019) PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol 59:125–132

    Article  CAS  Google Scholar 

  27. Ma J, Xue M (2018) LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-β pathway. Biosci Rep. https://doi.org/10.1042/BSR20180936

    Article  PubMed  PubMed Central  Google Scholar 

  28. Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Scalia M, Magnano A, Caltabiano R, Barbagallo D, Biondi A, Cappellani A, Basile F, Di Pietro C, Purrello M, Ragusa M (2018) lncrna UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions. Mol Ther Nucleic Acids 12:229–241

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study is supported by Natural Science Fund of China (U1702281, 81670551 and 81873584), National Key R&D Program of China (2017YFA0205404). The abstract has been presented in 26th United European Gastroenterology Week Vienna 2018 as a poster.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jinhang Gao.

Ethics declarations

Conflict of interest

All authors declare no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, C., Gan, C., Xiao, Y. et al. High expression of long non-coding RNA Linc-A associates with poor survival in patients with colorectal cancer. Mol Biol Rep 47, 7497–7504 (2020). https://doi.org/10.1007/s11033-020-05809-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-020-05809-5

Keywords

Navigation